Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care.

52W Range

2ndpctl

Volume

0.11×avg

Market Cap

817906USD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Enveric Biosciences, Inc.

ENVBNASDAQ Capital Market·USD·Closed

Enveric Biosciences, Inc.

ENVBNASDAQ·USD·Closed

$1.37

+0.00%

$1.37

+$0.00 (0.00%)

52W Range

2ndpctl

Volume

0.11×avg

Mkt Cap

817906USD

P/E

-0.1TTM

Div Yield

–ann

ENVB: Enveric Biosciences, Inc. Stock Analysis | finqOS